Detalles de la búsqueda
1.
Magnetic Resonance Deep Learning Radiomic Model Based on Distinct Metastatic Vascular Patterns for Evaluating Recurrence-Free Survival in Hepatocellular Carcinoma.
J Magn Reson Imaging
; 2023 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37888871
2.
Lymphocyte-C-reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study.
Liver Int
; 41(2): 378-387, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32562336
3.
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma.
BMC Cancer
; 20(1): 607, 2020 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32600297
4.
Association between Early Immune-Related Adverse Events and Survival in Patients Treated with PD-1/PD-L1 Inhibitors.
J Clin Med
; 12(3)2023 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769385
5.
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.
J Clin Oncol
; 41(10): 1898-1908, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525610
6.
Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models.
J Hepatocell Carcinoma
; 8: 253-261, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907695
7.
The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE.
Aging (Albany NY)
; 13(4): 5358-5368, 2021 02 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589570
8.
The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.
Cancer Med
; 10(16): 5466-5474, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212527
9.
Prognostic Value of the Preoperative Lymphocyte-C-Reactive Protein Ratio in Hepatocellular Carcinoma Patients Treated with Curative Intent: A Large-Scale Multicentre Study.
J Inflamm Res
; 14: 2483-2495, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34140796
10.
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy.
J Inflamm Res
; 14: 3879-3890, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34408469
11.
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 167-176, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33791252
12.
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
JAMA Netw Open
; 4(9): e2125055, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34515782
13.
Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma.
Dis Markers
; 2020: 4269460, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32695241
14.
A Novel Prognostic Nomogram for Patients With Recurrence of Intrahepatic Cholangiocarcinoma After Initial Surgery.
Front Oncol
; 10: 434, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32300559
15.
A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma.
Cancer Med
; 9(1): 62-76, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31701652
16.
Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic Study.
Front Oncol
; 10: 573, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32432036
17.
Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation.
Cancer Med
; 9(9): 2997-3005, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32108433
18.
Anatomical versus Non-anatomical Resection for Hepatocellular Carcinoma with Microscope Vascular Invasion: A Propensity Score Matching Analysis.
J Cancer
; 10(17): 3950-3957, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31417639
19.
NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma.
Cell Death Dis
; 10(5): 369, 2019 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31068575
20.
Risk factors of extra-hepatic progression after transarterial chemoembolization for hepatocellular carcinoma patients: a retrospective study in 654 cases.
J Cancer
; 10(20): 5007-5014, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31598173